SIIM

Deep Learning Helps Predict Y90-RE Response in HCC Patients

May 25, 2021

Using a deep convolutional neural network can improve providers’ ability to predict how patients with hepatocellular carcinoma will respond to Y90-RE treatment, enabling them to offer additional therapies, if necessary.